Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2012
04/17/2012CA2559630C Fasudil-containing preparation and method of improving stability thereof
04/17/2012CA2528710C A method of treating an anxiety disorder
04/17/2012CA2513717C Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
04/17/2012CA2494987C Isoxazoles and their use as modulators of metabotropic glutamate receptor-5
04/17/2012CA2493843C Azolidinone-vinyl fused-benzene derivatives
04/17/2012CA2488120C Pharmaceutical composition for improving cerebral function and method for improving cerebral function
04/17/2012CA2487699C A buffered, liquid nicotine composition for pulmonary administration
04/17/2012CA2469138C Inhibitors of cytosolic phospholipase a2
04/17/2012CA2468948C Preventives or remedies for alzheimer's disease or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
04/17/2012CA2427844C Naphthalene derivatives
04/17/2012CA2408380C Recombinant human cln2 protein and methods of its production and use
04/17/2012CA2402894C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method
04/17/2012CA2377607C Neurotrophic factor receptor
04/17/2012CA2372181C Adjuvant combination formulations
04/17/2012CA2371625C Polyamines and their use in therapy
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/17/2012CA2145778C Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
04/12/2012WO2012048330A2 Treatment of motor neuron disease
04/12/2012WO2012048294A2 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
04/12/2012WO2012048164A2 Porphyrin treatment of neurodegenerative diseases
04/12/2012WO2012048152A2 Probiotic therapies for autism
04/12/2012WO2012048129A2 Inhibitors of polo-like kinase
04/12/2012WO2012047926A2 Sulfonamide-containing compounds
04/12/2012WO2012047918A1 Anti-epileptogenic agents
04/12/2012WO2012047763A2 Stimulation of neuroregeneration by flavonoid glycosides
04/12/2012WO2012047287A2 Upregulation of opioid receptors for pain management
04/12/2012WO2012047172A1 Picropodophyllin monohydrate or polymorph a in cancer therapy
04/12/2012WO2012047171A1 Picropodophyllin polymorphs b or c for use in cancer therapy
04/12/2012WO2012047063A2 Pharmaceutical composition for aiding dementia treatment or treating dementia, containing angelica gigas nakai extract only, ginkgo leaf extract only, or mixture of angelica gigas nakai extract and ginkgo leaf extract
04/12/2012WO2012046993A2 Composition for preventing or treating dementia containing prunus mume extract
04/12/2012WO2012046902A1 Method for treating parkinson's disease through the control of the vdac1 protein
04/12/2012WO2012046771A1 Cycloalkane compound
04/12/2012WO2012046132A1 Quinazoline compounds as sodium channel blockers
04/12/2012WO2012046062A1 Use of prodrugs to avoid gi mediated adverse events
04/12/2012WO2012045883A1 Cyclopropylamine inhibitors of oxidases
04/12/2012WO2012045804A1 Hdac inhibitors to treat charcot-marie-tooth disease
04/12/2012WO2012045451A1 Novel therapeutic treatment of progranulin-dependent diseases
04/12/2012WO2012045283A1 Dalfampridine polymorph, preparation therefor, and application thereof
04/12/2012WO2012045118A1 Combination therapy for the treatment of depression and other non-infectious diseases
04/12/2012WO2012023623A3 Agent for treatment of hunter syndrome
04/12/2012WO2012007847A3 Pharmaceutical compositions and methods of treatment
04/12/2012WO2011159974A3 TARGETING THE ALPHA3 SUBUNIT OF Na+K+-ATPase FOR THE TREATMENT OF COUGH WITH SULFENAMIDES
04/12/2012WO2011159945A9 Methods for treating neurological conditions
04/12/2012WO2011156479A3 Trkb agonists and methods of use
04/12/2012WO2011132966A3 Transdermal absorption preparation
04/12/2012WO2011130615A3 Preparation of lacosamide
04/12/2012WO2011058262A8 Xenon-based inhalable drug for treating or preventing induced dyskinesia
04/12/2012WO2011043788A8 Daptomycin for multiple sclerosis
04/12/2012WO2011041920A8 Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing
04/12/2012US20120088911 Novel carboxylic acid derivatives, their preparation and use
04/12/2012US20120088841 Composition and a method of treating cns disorders and hyperpigmentation
04/12/2012US20120088839 Composition for regulating cellular senescence comprising [n-2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
04/12/2012US20120088837 Tetralin and indane derivatives and uses thereof
04/12/2012US20120088835 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
04/12/2012US20120088832 Anti-Adhesive Barrier Membrane Using Alginate and Hyaluronic Acid for Biomedical Applications
04/12/2012US20120088826 Process for production of optically active amine derivatives
04/12/2012US20120088825 Compounds with activity at estrogen receptors
04/12/2012US20120088822 Low-dose doxepin for treatment of sleep disorders in elderly patients
04/12/2012US20120088818 Conformation-selective nucleic acid inhibitors of ampa glutamate receptors
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088809 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
04/12/2012US20120088798 Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors
04/12/2012US20120088794 Aminotetralin compounds as mu opioid receptor antagonists
04/12/2012US20120088793 Bicyclic Compounds and Methods of Making and Using Same
04/12/2012US20120088792 Pyridin-2-YL Methylamine Derivatives for Treating Opiate Dependence
04/12/2012US20120088791 Amidobipiperidinecarboxylate m1 allosteric agonists, analogs and derivatives thereof, and methods of making and using same
04/12/2012US20120088790 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
04/12/2012US20120088789 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/12/2012US20120088787 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
04/12/2012US20120088785 New uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
04/12/2012US20120088784 Substituted Aromatic Compounds and Pharmaceutical Uses thereof
04/12/2012US20120088783 Chroman derivatives
04/12/2012US20120088782 Lpa receptor antagonist
04/12/2012US20120088780 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/12/2012US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/12/2012US20120088776 Treatment of mammalian disorders mediated by alpha-anhydrase isoforms
04/12/2012US20120088775 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof
04/12/2012US20120088772 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
04/12/2012US20120088770 Alpha helix mimetics and methods relating thereto
04/12/2012US20120088769 Salts of arylsulfonamide ccr3 antagonists
04/12/2012US20120088762 Compounds for enzyme inhibition
04/12/2012US20120088760 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
04/12/2012US20120088759 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
04/12/2012US20120088756 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
04/12/2012US20120088755 Novel Compounds
04/12/2012US20120088753 Pyrrolopyrimidines and used as kinase inhibitors
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088749 S1P Receptor Modulating Compounds and Use Thereof
04/12/2012US20120088748 Heterocyclic compounds
04/12/2012US20120088747 Sulfonamide containing compounds and uses thereof
04/12/2012US20120088746 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/12/2012US20120088744 Compositions for treating cmt and related disorders
04/12/2012US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
04/12/2012US20120088738 Inhibitors of fatty acid amide hydrolase
04/12/2012US20120088737 Novel acyl guanidine derivatives
04/12/2012US20120088736 [4-(6-HALO-7-Substituted-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREAS and Forms and Methods Related Thereto
04/12/2012US20120088732 Therapeutic composition comprising a botulinum neurotoxin
04/12/2012US20120088731 Method for treating parkinson's disease through regulating vdac1 protein
04/12/2012US20120088727 Rspondins as modulators of angiogenesis and vasculogenesis
04/12/2012US20120088716 Polypeptide Protracting Tags
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1833